BEDFORD, Mass., (September 2, 2009) - Hologic, Inc. (NASDAQ: HOLX) today announced
that Glenn Muir, Chief Financial Officer, will present at the 2009 Morgan Stanley Global
Healthcare Unplugged Conference in New York City on Tuesday, September 15, 2009, at 2:45
p.m. (Eastern).

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation
on the investor section of the company's website at www.hologic.com/investor. An archive of
the presentation will be available for replay following the conference.

About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products,
medical imaging systems and surgical products dedicated to serving the healthcare needs of
women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical,
and skeletal health. Hologic provides a comprehensive suite of technologies with products for
mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical
cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment,
preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic
products including HPV and reagents for a variety of DNA and RNA analysis applications.